Brazil’s Butantan aims to supply 40 million doses of its COVID-19 jab by year-end
BRASILIA — Brazil’s Butantan Institute could supply at least 40 million doses of its own COVID-19 vaccine called Butanvac in the fourth quarter of 2021, said Director Dimas Covas on Thursday.
Speaking before a Senate panel investigating the federal government’s handling of the pandemic, Covas said clinical trials of the new vaccine can be concluded quickly, though they still need to be authorized by Brazilian health regulator Anvisa.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.